万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>期刊大全 >>中国国际期刊>>医学综合

Molecular Biomedicine(OA期刊)(国际刊号) (官网投稿)

简介
Molecular Biomedicine(一年1卷),创刊于2020年,是由世界著名的科技期刊出版公司Springer Nature和四川省国际医学交流促进会合作创办发行的全英文生物医学专业期刊,是一本同行评审的在线发表开放获取(Open Access)期刊,将及时出版基于分子角度的生物医学领域的基础研究与临床研究工作,重点关注人类疾病的发生机制、预防、诊断和治疗等方面的研究进展,力争成为生物医学领域中具...[显示全部]
本刊为:目次收录(维普), 知网外文库,外文期刊,
征稿信息

万维提示:

1、该刊只有国际刊号!

2、投稿方式:在线投稿。

3、官网网址(主办单位官网进入)

https://www.springer.com/journal/43556

4、投稿系统:https://www.editorialmanager.com/mbmc

5、主办单位官网:https://www.scimea.cn/

(四川省国际医学交流促进会)

6、期刊刊期:年刊,一年出版一卷。

2025611日星期三

                       

 

Submission guidelines

【官网信息】

 

Instructions for Authors

Article-Processing Charge

Molecular Biomedicine is an Open Access journal and an article-processing charge (APC) is levied on articles that are accepted for publication.

Currently, the APC for this journal is covered by Sichuan International Medical Exchange & Promotion Association, so authors do not need to pay.

As of January 1, 2024, for articles accepted for publication in Molecular Biomedicine, regardless of when it is submitted to the journal, the author will need to pay an APC. The APC for articles accepted in 2024 is €2090/£1790/$2490.

Article Types

Research

Articles describe original research, and should be 3000-6000 words (excluding the abstract, tables, figure legends and references) and contain no more than 8 display items (such as figures or tables).

Research papers should contain an unstructured abstract with up to 250 words. Additional display items will be published online as Supplemental Information.

Review

A review should be a comprehensive synthesis and/or analysis of specific topics. A short Introduction giving the rationale for the review should be followed by sections with appropriate subheadings, followed by a conclusions section at the end. The standard footer headings (Acknowledgements, Contributions, Competing Interests, and Funding) are required. All invited reviews will undergo peer review prior to acceptance.

Review papers should contain an unstructured abstract with up to 250 words, at least 3000 words in length. Review papers should contain around 4-8 figures and tables in total, around 100-500 references.

Letter

Letters provide rapid and concise report of a novel finding that is brief in nature but is of general interest to the field. There should be no more than 10 authors.

No abstract needed for Letter papers. It should include 1200 words max excluding references, figures and tables. A letter should contain, but no more than 1 display item and references are limited to 5.

Research Highlight

Research Highlights discuss the main advances made by the paper as well as putting the finds of the study into the proper context of the field.

A brief stand first of one or two sentences should serve as an abstract. A research highlight paper should include 1000 words max excluding references, figures and tables, and contain, but no more than 1 display item and references are limited to 5. A consensus should be a public statement on professional knowledge in the field of molecular biomedicine, and it is expected to be generally agreed upon as an evidence-based, state-of-the-art knowledge by a representative group of experts in that area.

Consensus

Consensus papers should contain an unstructured Abstract with up to 250 words. Four to Six Keywords representing the main content of the article. The Background section should a concise summary of a search of the existing literature and the issue under discussion. The standard footer headings (Acknowledgements, Contributions, Competing Interests, and Funding) are required.

Manuscript Submission

Manuscript Submission

Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.

Permissions

Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.

Online Submission

Please follow the hyperlink “Submit manuscript” and upload all of your manuscript files following the instructions given on the screen.

Source Files

Please ensure you provide all relevant editable source files at every submission and revision. Failing to submit a complete set of editable source files will result in your article not being considered for review. For your manuscript text please always submit in common word processing formats such as .docx or LaTeX.

Title Page

Please make sure your title page contains the following information.

Title

The title should be concise and informative.

Author information

The name(s) of the author(s)

The affiliation(s) of the author(s), i.e. institution, (department), city, (state), country

A clear indication and an active e-mail address of the corresponding author

If available, the 16-digit ORCID of the author(s)

If address information is provided with the affiliation(s) it will also be published.

For authors that are (temporarily) unaffiliated we will only capture their city and country of residence, not their e-mail address unless specifically requested.

Large Language Models (LLMs), such as ChatGPT, do not currently satisfy our authorship criteria. Notably an attribution of authorship carries with it accountability for the work, which cannot be effectively applied to LLMs. Use of an LLM should be properly documented in the Methods section (and if a Methods section is not available, in a suitable alternative part) of the manuscript. The use of an LLM (or other AI-tool) for "AI assisted copy editing" purposes does not need to be declared. In this context, we define the term "AI assisted copy editing" as AI-assisted improvements to human-generated texts for readability and style, and to ensure that the texts are free of errors in grammar, spelling, punctuation and tone. These AI-assisted improvements may include wording and formatting changes to the texts, but do not include generative editorial work and autonomous content creation. In all cases, there must be human accountability for the final version of the text and agreement from the authors that the edits reflect their original work.

Abstract

Please provide an abstract of 150 to 250 words. The abstract should not contain any undefined abbreviations or unspecified references.

For life science journals only (when applicable)

Trial registration number and date of registration for prospectively registered trials

Trial registration number and date of registration, followed by “retrospectively registered”, for retrospectively registered trials

Keywords

Please provide 4 to 6 keywords which can be used for indexing purposes.

......

更多详情:

https://link.springer.com/journal/43556/submission-guidelines#Instructions%20for%20Authors_Editorial%20procedure

  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭